NDC 16729-322 – Olmesartan medoxomil
Olmesartan Medoxomil 40 mg/1 · Tablet, Film Coated · Oral
Product NDC16729-322
Product details
- Brand name
- Olmesartan medoxomil
- Generic name
- Olmesartan medoxomil
- Labeler
- Accord Healthcare Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA207662
- Marketed since
- April 27, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Angiotensin 2 Receptor Blocker
Active ingredients
- Olmesartan Medoxomil 40 mg/1
Uses, dosage, side effects and warnings for Olmesartan Medoxomil →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 16729-322-10 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-322-10) | Apr 27, 2017 |
| 16729-322-15 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-322-15) | Apr 27, 2017 |
| 16729-322-17 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-322-17) | Apr 27, 2017 |
Other Olmesartan Medoxomil products
- 50090-4451 Olmesartan Medoxomil 40 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-6686 Olmesartan Medoxomil 20 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-6606 Olmesartan Medoxomil 20 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-7681 Olmesartan Medoxomil 40 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-7810 Olmesartan Medoxomil 40 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-7680 Olmesartan Medoxomil 40 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-3487 Olmesartan Medoxomil 40 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-3471 Olmesartan Medoxomil 20 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 16729-320 Olmesartan Medoxomil 5 mg/1 · Tablet, Film Coated · Accord Healthcare Inc.
- 16729-321 Olmesartan Medoxomil 20 mg/1 · Tablet, Film Coated · Accord Healthcare Inc.
- 62332-131 Olmesartan Medoxomil 5 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-132 Olmesartan Medoxomil 20 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.